Clinical perspectives of emerging pathogens in bleeding disorders

[1]  M. Turner,et al.  Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products , 2006, British journal of haematology.

[2]  Anthony J McMichael,et al.  Social and environmental risk factors in the emergence of infectious diseases , 2004, Nature Medicine.

[3]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[4]  Y. Chan,et al.  Recombinant Human Enterovirus 71 , 2004, Emerging infectious diseases.

[5]  J. Montaner,et al.  Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. , 2004, The New England journal of medicine.

[6]  P. Volberding,et al.  Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. , 2004, The New England journal of medicine.

[7]  J. Rockstroh,et al.  HIV and hepatitis C virus co-infection. , 2004, The Lancet. Infectious diseases.

[8]  J. Wagenaar,et al.  Dengue: an arthropod-borne disease of global importance , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[9]  D. Butler.  Fatal fruit bat virus sparks epidemics in southern Asia , 2004, Nature.

[10]  P. Klapper,et al.  Detection of BK virus and JC virus DNA in urine samples from immunocompromised (HIV-infected) and immunocompetent (HIV-non-infected) patients using polymerase chain reaction and microplate hybridisation. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[11]  C. Thio.  Management of chronic hepatitis B in the HIV-infected patient. , 2004, The AIDS reader.

[12]  M. Enserink.  Nipah Virus (or a Cousin) Strikes Again , 2004, Science.

[13]  S. Darby,et al.  The impact of HIV on mortality rates in the complete UK haemophilia population , 2004, AIDS.

[14]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[15]  I. Vorberg,et al.  Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. , 2004, The Journal of infectious diseases.

[16]  R. Dodd,et al.  Emerging infectious threats to the blood supply. , 2004, Annual review of medicine.

[17]  Shin-Ru Shih,et al.  Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. , 2004, JAMA.

[18]  T. Solomon,et al.  Neurovirulence and host factors in flavivirus encephalitis--evidence from clinical epidemiology. , 2004, Archives of virology. Supplementum.

[19]  M. Enserink.  Emerging infectious diseases. Nipah virus (or a cousin) strikes again. , 2004, Science.

[20]  B. Ritchie.  Tissue archives to track blood borne pathogens in people receiving blood products. , 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[21]  G. Pomper,et al.  Risks of transfusion-transmitted infections: 2003. , 2003, Current opinion in hematology.

[22]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[23]  J. Sejvar,et al.  West Nile virus in the United States: an update on an emerging infectious disease. , 2003, American family physician.

[24]  P. Simmonds,et al.  Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors , 2003, Transfusion.

[25]  J. Astermark,et al.  Consensus perspectives on prophylactic therapy for haemophilia: summary statement , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[26]  S. Kleinman,et al.  Current and emerging infectious risks of blood transfusions. , 2003, JAMA.

[27]  A. Boner,et al.  TT Virus in the Nasal Secretions of Children with Acute Respiratory Diseases: Relations to Viremia and Disease Severity , 2003, Journal of Virology.

[28]  A. Vats,et al.  Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults1 , 2003, Transplantation.

[29]  Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[30]  Manuel Amador,et al.  Texas Lifestyle Limits Transmission of Dengue Virus , 2003, Emerging infectious diseases.

[31]  Joshua Lederberg,et al.  Microbial Threats to Health: Emergence, Detection, and Response , 2003 .

[32]  N. Komar.  West Nile virus: epidemiology and ecology in North America. , 2003, Advances in virus research.

[33]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[34]  J. Goedert,et al.  Factors predictive of death among HIV‐uninfected persons with haemophilia and other congenital coagulation disorders , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[35]  B. Biggerstaff,et al.  Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City , 2002, Transfusion.

[36]  S. Hino.  TTV, a new human virus with single stranded circular DNA genome , 2002, Reviews in medical virology.

[37]  S V Tiroumourougane,et al.  Japanese viral encephalitis , 2002, Postgraduate medical journal.

[38]  Kazuya Nakamura,et al.  Feline Host Range of Canine parvovirus: Recent Emergence of New Antigenic Types in Cats , 2002, Emerging infectious diseases.

[39]  M. Chamberland,et al.  Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  Kuender D Yang,et al.  Clinical Manifestations and Laboratory Assessment in an Enterovirus 71 Outbreak in Southern Taiwan , 2002, Scandinavian journal of infectious diseases.

[41]  D. Vaughn,et al.  Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. , 2002, Current topics in microbiology and immunology.

[42]  B. Sampson,et al.  West Nile Encephalitis , 2001, Annals of the New York Academy of Sciences.

[43]  R. Colvin,et al.  BK virus in solid organ transplant recipients: an emerging syndrome. , 2001, Transplantation.

[44]  I. Macgregor,et al.  Immunoassay of human plasma cellular prion protein , 2001, Transfusion.

[45]  A. Dobson,et al.  Emerging infectious pathogens of wildlife. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[46]  P. Giangrande,et al.  Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia. , 2001 .

[47]  P. Giangrande,et al.  Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

[48]  Natale Scaramozzino,et al.  Comparison of Flavivirus Universal Primer Pairs and Development of a Rapid, Highly Sensitive Heminested Reverse Transcription-PCR Assay for Detection of Flaviviruses Targeted to a Conserved Region of the NS5 Gene Sequences , 2001, Journal of Clinical Microbiology.

[49]  R. Rubenstein,et al.  A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins , 2001, Transfusion.

[50]  Hoots Wk.  History of plasma-product safety. , 2001 .

[51]  T. Solomon,et al.  Dengue and other emerging flaviviruses. , 2001, The Journal of infection.

[52]  W. Hoots.  History of plasma-product safety. , 2001, Transfusion medicine reviews.

[53]  Berger.  Progressive Multifocal Leukoencephalopathy. , 2020, Current treatment options in neurology.

[54]  J. Platt.  Zoonosis in xenotransplantation. , 2000, Transplantation proceedings.

[55]  A. Degener,et al.  Polyomavirus persistence in lymphocytes: prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. , 2000, The Journal of general virology.

[56]  D. U. Mehnert,et al.  Molecular characterization of canine parvovirus in Brazil by polymerase chain reaction assay. , 2000, Veterinary microbiology.

[57]  L. Cowan,et al.  Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. , 2000, Blood.

[58]  H. Field,et al.  Nipah virus: a recently emergent deadly paramyxovirus. , 2000, Science.

[59]  H. Westbury.  Hendra virus disease in horses. , 2000, Revue scientifique et technique.

[60]  H. Ning,et al.  Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. , 1999, The Pediatric infectious disease journal.

[61]  T. Yeh,et al.  Neurologic complications in children with enterovirus 71 infection. , 1999, The New England journal of medicine.

[62]  C. Parrish.  Host range relationships and the evolution of canine parvovirus. , 1999, Veterinary microbiology.

[63]  H. Ishiko,et al.  Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. , 1999, Pediatric neurology.

[64]  R. Weiss,et al.  Host range and interference studies of three classes of pig endogenous retrovirus. , 1999, Journal of virology.

[65]  DavidJ. Evans,et al.  Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy , 1997, The Lancet.

[66]  A. Vandamme,et al.  The presence of a divergent T-lymphotropic virus in a wild-caught pygmy chimpanzee (Pan paniscus) supports an African origin for the human T-lymphotropic/simian T-lymphotropic group of viruses. , 1996, The Journal of general virology.

[67]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[68]  U. Zweifel,et al.  United Nations Environment Programme , 2005, Essential Concepts of Global Environmental Governance.

[69]  M. Mochizuki,et al.  Antigenic and genomic variabilities among recently prevalent parvoviruses of canine and feline origin in Japan. , 1993, Veterinary microbiology.

[70]  C. Parrish,et al.  Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo , 1992, Journal of virology.

[71]  L. Evans,et al.  Direct determination of the point mutation rate of a murine retrovirus , 1992, Journal of virology.

[72]  G. Baatz.  [Ten years of clinical experiences with canine parvovirus infection CPV-2 infection)]. , 1992, Tierarztliche Praxis.

[73]  R. Rico-Hesse,et al.  Venezuelan haemorrhagic fever , 1991, The Lancet.

[74]  Hilgartner Mw.  The need for recombinant factor VIII: historical background and rationale. , 1991 .

[75]  M. Hilgartner.  The need for recombinant factor VIII: historical background and rationale. , 1991, Seminars in hematology.

[76]  R. Holman,et al.  Human T-Lymphotropic Retrovirus Type III / Lymphadenopathy-Associated Virus Antibody: Association With Hemophiliacs' Immune Status and Blood Component Usage , 1985 .

[77]  A. Landay,et al.  Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings. , 1983, Annals of internal medicine.

[78]  Bastianello Ss.  Canine parvovirus myocarditis: clinical signs and pathological lesions encountered in natural cases. , 1981 .

[79]  S. Bastianello.  Canine parvovirus myocarditis: clinical signs and pathological lesions encountered in natural cases. , 1981, Journal of the South African Veterinary Association.

[80]  H. Hoogstraal,et al.  An epizootic of Rift Valley fever in Egypt in 1977 , 1979, Veterinary Record.